Eamon Ryan (Dublin Bay South, Green Party)
Link to this: Individually | In context | Oireachtas source

390. To ask the Minister for Health if the drug osimertinib will be made available to persons with EGFR-positive non-small cell lung cancer; the cost-benefit analysis undertaken regarding the provision of the drug; and the reason it is not available here in view of the fact that it is widely available across the EU. [41956/18]

Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the pricing and reimbursement of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.